grant

Investigating personalized approaches to de-intensify therapy for nodular lymphocyte-predominant Hodgkin lymphoma

Organization STANFORD UNIVERSITYLocation STANFORD, UNITED STATESPosted 1 Aug 2024Deadline 31 Jul 2029
NIHUS FederalResearch GrantFY2025AddressAfter CareAfter-TreatmentAftercareAssayB lymphomaB-Cell LymphomasBioassayBioinformaticsBiological AssayBiometricsBiometryBiopsyBiostatisticsBlood PlasmaBlood SampleBlood specimenBody TissuesBrill-Symmers DiseaseCancer BiologyCardiac ToxicityCardiotoxicCardiotoxicityCardiovascular DiseasesCareer Development AwardsCareer Development Awards and ProgramsCareer Development Programs K-SeriesCell BodyCellsCessation of lifeChemotherapy and RadiationChemotherapy and/or radiationClinicalClinical ProtocolsClinical TrialsCoronary ArteriosclerosisCoronary Artery DiseaseCoronary Artery DisorderCoronary AtherosclerosisCustomDNA mutationDataDeathDevelopmentDevelopment PlansDiagnosisDiagnosticDiseaseDisorderDoctor of PhilosophyEcologic SystemsEcological SystemsEcosystemFollicle Center LymphomaFollicular LymphomaFollicular Non-Hodgkin's LymphomaFoundationsFutureGene ExpressionGene Expression MonitoringGene Expression Pattern AnalysisGene Expression ProfilingGenesGeneticGenetic ChangeGenetic RiskGenetic defectGenetic mutationGenomicsGenotypeGerminoblastic SarcomaGerminoblastomaGiant Follicular LymphomaGoalsHematologic CancerHematologic MalignanciesHematologic NeoplasmsHematological MalignanciesHematological NeoplasmsHematological TumorHematopoietic CancerHereditaryHistiocytic LymphomaHodgkin DiseaseHodgkin DisorderHodgkin lymphomaHodgkin'sHodgkin's LymphomaHodgkin's diseaseHodgkins lymphomaHumanHybrid captureHybridization captureImmuneImmunesInheritedK-AwardsK-Series Research Career ProgramsKnowledgeLarge-Cell LymphomasLymphatic cellLymphocyteLymphocyticLymphomaMalignantMalignant - descriptorMalignant Hematologic NeoplasmMalignant LymphogranulomaMalignant LymphomaMeasurableMeasuresMentorshipMethodsModern ManMorbidityMorbidity - disease rateMutateMutationNodular LymphomaOrphan DiseaseOutcomePatient SelectionPatientsPersonalized medical approachPh.D.PhDPhenotypePlasmaPlasma SerumPredictive FactorPrognostic MarkerProgression-Free SurvivalsRNA SeqRNA sequencingRNAseqRaceRacesRadiation OncologyRadiation therapyRadiotherapeuticsRadiotherapyRare DiseasesRare DisorderRecurrenceRecurrentRegulationRelapseResearchResearch Career ProgramReticuloendothelial System, Serum, PlasmaReticulolymphosarcomaReticulosarcomaReticulum-Cell SarcomaRiskRisk-associated variantSamplingSelection for TreatmentsSomatic CellTestingTissuesToxic effectToxicitiesTrainingTranscript Expression AnalysesTranscript Expression AnalysisTranslational Research EnterpriseTumor BurdenTumor LoadUniversitiesactive methodactive techniqueactive treatmentanalyze gene expressionatherosclerotic coronary diseasebiomarker identificationcancer immunologycardiovascular disease riskcardiovascular disordercardiovascular disorder riskcardiovascular riskcardiovascular risk factorcareercareer developmentcell transformationcell typechemo/radiation therapychemotherapychemotherapy and radiotherapyclinically actionablecomputer based predictionconferenceconventioncoronary arterial diseasecustomsdata managementdesigndesigningdevelopmentaldisease riskdisorder riskexperiencegene expression analysisgene expression assaygenome mutationgenomic biomarkergenomic markergenotyped patientsglobal gene expressionglobal transcription profilehigh riskhybridization-based captureidentification of biomarkersidentification of new biomarkersimprovedindividualized approachliquid biopsylymph cellmalignant lymphocytemarker identificationmedical collegemedical schoolsmortalityneoplasm immunologynovelorphan disorderoutcome predictionpersonalization of treatmentpersonalized approachpersonalized medicinepersonalized therapypersonalized treatmentpost treatmentprecision approachpredict clinical outcomepredictive modelingprofessorprognosticprognostic abilityprognostic biomarkerprognostic indicatorprognostic powerprognostic utilityprognostic valueprogramsprogression riskprospectiveprotein biomarkersprotein markersracialracial backgroundracial originradiation or chemotherapyradiation treatmentrisk allelerisk generisk genotyperisk locirisk locusrisk variantscRNA sequencingscRNA-seqschool of medicineselection of treatmentsingle cell RNA-seqsingle cell RNAseqsingle cell expression profilingsingle cell transcriptomic profilingsingle-cell RNA sequencingspatial RNA sequencingspatial gene expression analysisspatial gene expression profilingspatial resolved transcriptome sequencingspatial transcriptome analysisspatial transcriptome profilingspatial transcriptome sequencingspatial transcriptomicsspatially resolved transcriptomicsspatio transcriptomicsstandard carestandard treatmentstatisticssummitsurveillance strategysymposiasymposiumtailored approachtargeted sequencingtherapy optimizationtherapy selectiontooltranscriptional profilingtranscriptometranscriptome sequencingtranscriptomic sequencingtranscriptomicstransformed cellstranslation research enterprisetranslational research programtreatment optimizationtreatment selectiontreatment with radiationtumortumor DNAtumor cell DNAtumor immunologytumor-specific DNAwork groupworking group
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Description preview

PROJECT SUMMARY/ABSTRACT:
Michael Binkley, MD, MS is an Assistant Professor of Radiation Oncology at Stanford

University School of Medicine. His long-term career goal is to combine his expertise in managing

patients with hematologic malignancies with his research expertise in statistics, genomics, and

cancer biology to develop improved treatment…

🔒

Full details available on the Agency plan

Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.

Start 7-day free trial — $29.99/mo →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →
Investigating personalized approaches to de-intensify therapy for nodular lymphocyte-predominant Hodgkin lymphoma — STAN | Dev Procure